ITIF

Mobilizing for Techno-Economic War, Part 4: Transforming Education and Workforce Policy
The U.S. education and workforce development system is ill-suited to winning the economic power industry war with China. It’s time for systemic reforms to produce students and workers with skills and capabilities that national power industries need.

America Needs an Industrial Strategy for Motor Vehicles
U.S. automotive competitiveness has severely faltered. The federal government needs a comprehensive national strategy to revitalize the industry’s competitiveness, especially in the face of Chinese EVs.

The Hamilton Index, 2026: China’s Dominance in Advanced Industries Is Growing
China now produces nearly one-quarter of global output in the 10 advanced industries that make up ITIF’s Hamilton Index, outpacing all other nations. America and the West must recognize that China’s gains are coming at the expense of their techno-economic and national power.
Explaining the Relative Competitive Decline of America’s Automotive Industry

The competitiveness of the auto industry of the United States has waxed and waned over the past 60 years and is clearly not the globally dominant behemoth it once was. To bolster the industry’s competitiveness, policymakers first must understand why it has faltered and the challenges it faces moving forward.
Mobilizing for Techno-Economic War, Part 2: Slowing China’s Advance

Boosting U.S. competitiveness in national power industries is necessary, but not sufficient to avoid losing to China. America also must take measures to slow the PRC’s progress toward global dominance. This report provides more than 100 actionable recommendations for the administration and Congress. Western allies should take many of the same steps.
Lessons From Europe’s Loss of Biopharma Leadership, and Its Attempts to Recover

Europe once led the world in biopharmaceutical innovation, but it lost ground after adopting policies that weakened incentives for R&D and innovation. America must learn from Europe’s experience to preserve its own biopharma leadership and the related economic benefits and access to the most innovative drugs.
The Alarming Performance of US Advanced Technology Product Trade

Over the last decade, U.S. trade performance has deteriorated significantly in advanced industries. That is a major problem because these industries have high fixed costs and require substantial investments in R&D, so they depend on large customer bases to achieve scale economies and remain globally competitive.
Policy Reforms to Launch US Space Innovation

Competitiveness in the global space economy should be a priority for the United States, but ineffective regulations weigh down the American commercial space industry. While last year’s executive order was a good start, additional regulatory reforms are necessary to address key roadblocks to U.S. space capabilities.



















